Markers of inflammation are associated with clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab
Mario Sznol, Mayer Fishman, Bernard Escudier, David F McDermott, Harriet Kluger, Walter M Stadler, Jose Perez-Gracia, Douglas G McNeel, Brendan D Curti, Michael R Harrison, Elizabeth R Plimack, Leonard Appleman, Lawrence Fong, Charles G Drake, Tina C Young, Scott D Chasalow, Petra Ross-MacDonald, Jason S Simon, Dana Walker, Toni K Choueiri
Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P197; DOI: 10.1186/2051-1426-3-S2-P197